Anti-Hsp27 抗体 [EPR5477]
Anti-Hsp27 antibody [EPR5477]
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
5
(2 Reviews)
|
(14 Publications)
Rabbit Recombinant Monoclonal Hsp27 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, African green monkey samples. Cited in 14 publications.
別名を表示する
HSP27, HSP28, HSPB1, Heat shock protein beta-1, HspB1, 28 kDa heat shock protein, Estrogen-regulated 24 kDa protein, Heat shock 27 kDa protein, Heat shock protein family B member 1, Stress-responsive protein 27, HSP 27, SRP27
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Hsp27 antibody [EPR5477] (AB109376)
Overlay histogram showing wild-type HAP1 (green line) and HSPB1 knockout HAP1 cells (red line) stained with ab109376. The cells were fixed with 4% formaldehyde (10 min) and then permeabilized with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (ab109376, 1μg/ml) for 30 min at 22°C. The secondary antibody used was Alexa Fluorr® 488 goat anti-rabbit IgG (H&L) presorbed (ab150081) at 1/2000 dilution for 30 min at 22°C. A rabbit IgG isotype control antibody (ab172730) was used at the same concentration and conditions as the primary antibody (HAP1 wildtype - black line, knockout HSPB1 HAP1- grey line). Unlabelled sample was also used as a control (this line is not shown for the purpose of simplicity). Acquisition of >5,000 events were collected using a 50 mW Blue laser (488nm) and 530/30 bandpass filter.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Hsp27 antibody [EPR5477] (AB109376)
Immunocytochemistry/Immunofluorescence analysis of HeLa (human cervix adenocarcinoma) cells labelling Hsp27 with purified ab109376 at 1/500. Cells were fixed with 100% methanol. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Nuclei were counterstained with DAPI (blue).
Secondary Only Control : PBS was used instead of the primary antibody as the negative control.
- WB
Lab
Western blot - Anti-Hsp27 antibody [EPR5477] (AB109376)
Lanes 1- 2 : Merged signal (red and green). Green - ab109376 observed at 23 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab109376 was shown to react with Hsp27 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261738 (knockout cell lysate ab256945) was used. Wild-type HeLa and Hsp27 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab109376 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Hsp27 antibody [EPR5477] (ab109376) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
HSPB1 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human HSPB1 (Hsp27) knockout HeLa cell line (<a href='/products/cell-lines/human-hspb1-hsp27-knockout-hela-cell-line-ab261738'>ab261738</a>)
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
- WB
Unknown
Western blot - Anti-Hsp27 antibody [EPR5477] (AB109376)
All lanes:
Western blot - Anti-Hsp27 antibody [EPR5477] (ab109376) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
COS-1 cell lysate at 10 µg
Lane 3:
BxPC-3 cell lysate at 10 µg
Lane 4:
HT-1376 cell lysate at 10 µg
Predicted band size: 23 kDa
Observed band size: 27 kDa
false
- WB
Lab
Western blot - Anti-Hsp27 antibody [EPR5477] (AB109376)
Lanes 1 - 4 : Merged signal (red and green). Green - ab109376 observed at 27 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab109376 was shown to specifically react with Hsp27 in wild-type HAP1 cells as signal was lost in Hsp27 knockout HAP1 cells. Wild-type and Hsp27 knockout samples were subjected to SDS-PAGE. ab109376 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Hsp27 antibody [EPR5477] (ab109376) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
Hsp27 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
MCF7 whole cell lysate at 20 µg
Predicted band size: 23 kDa
false
関連する標識済み抗体及び組成の異なる製品 (2)
-
HRP Anti-Hsp27 antibody [EPR5477]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Hsp27 antibody [EPR5477]
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Hsp27 plays a critical role in cellular stress response by regulating actin cytoskeleton dynamics and inhibiting apoptosis. It forms part of a complex that includes other proteins such as alphaB-crystallin. This complex facilitates the reorganization of proteins under stress conditions enhancing cell survival during oxidative stress or thermal shock. Hsp27 also modulates inflammatory responses and has been shown to affect cell migration.
Pathways
Hsp27 integrates into the apoptosis and inflammation pathways. It interacts with apoptotic machinery such as caspase proteins to protect cells by hindering apoptosome formation. Additionally Hsp27 can engage with pathways involving the nuclear factor-kappa B (NF-kB) impacting inflammatory signaling. CPTC (carboxyl-pyrene-trioctylamine) can modulate these pathways by altering Hsp27 function and interactions.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (14)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:470 PubMed40593489
2025
Applications
Unspecified application
Species
Unspecified reactive species
Drug development research 85:e22256 PubMed39285641
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of laboratory hematology 46:899-909 PubMed38826023
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:2856 PubMed38310132
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 15:645-658 PubMed38213722
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 63: PubMed37203411
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oncology 2022:4250531 PubMed35874632
2022
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:1593 PubMed34790799
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 45: PubMed33846793
2021
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 11:5650-5674 PubMed33897873
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com